EUVIMEDEUVIMED entdecken
Crossref

Identification of effective synthetic molecules against viral-induced cytokine release syndrome using in silico and in vitro approaches

Hira Noor Malik, Almas Jabeen, Sajda Ashraf, Saba Farooq, Hana'a Iqbal, Zaheer Ul-Haq

Molecular Diversity · 2025

DOI: 10.1007/s11030-025-11136-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Hira Noor Malik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karac…. Hauptthemen laut MEDLINE: Cytokine Release Syndrome, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute respiratory distress syndrome (ARDS) is the leading cause of mortality in pathogen-mediated lung inflammation. Viral-induced cytokine release syndrome (CRS) has emerged as a global pandemic, characterized by a hyperactive immune response and excessive cytokine production causing irreversible lung injury. This study aimed to evaluate FDA-approved drugs for their potential to target hyperactive immune response and SARS-CoV-2 viral replication simultaneously. Six potential 3-CLpro inhibitors were identified by molecular docking using MOE software, including ebastine (1), orlistat (2), atracurium besylate (3), piperaquine phosphate (4), valsartan (5), and acarbose (6), among which 1-3 binds strongly to the target protein with binding affinity of - 8.22, - 9.12, and - 7.81, kcal/mol, respectively. Additionally, all identified inhibitors except 4 revealed significant anti-viral potential, with a 50-100% reduction in SARS-CoV-2 plaques. Significant attenuation of phagocyte oxidative burst and inflammatory cytokines (IFN-γ, GM-CSF, IL-6, IL-2, IL-1β, TNF-α) demonstrated the immunomodulatory potential of these drugs. This study demonstrates the potential of pre-existing drugs to ameliorate the cytokine storm and oxidative damage with simultaneous anti-viral effects. The data provide pre-clinical support to develop these drugs as potential therapeutic agent against ARDS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytokine Release SyndromeAntiviral AgentsSARS-CoV-2HumansMolecular Docking SimulationCOVID-19CytokinesCOVID-19 Drug TreatmentAnimalsVirus ReplicationPandemicsComputer Simulation

Stichwörter der Autor:innen

Acute respiratory distress syndromeAnti-inflammatoryAnti-viralCytokine release syndrome

Substanzen

Antiviral AgentsCytokines

Autor:innen und Institutionen

  • Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan.
  • Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan. almas79_jabeen@yahoo.com.
  • National Institute of Virology, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan.
  • Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan. zaheer.qasmi@iccs.edu.

Zitieren

APA

Malik, H. N., Jabeen, A., Ashraf, S., Farooq, S., Iqbal, H., & Ul-Haq, Z. (2025). Identification of effective synthetic molecules against viral-induced cytokine release syndrome using in silico and in vitro approaches. Molecular Diversity. https://doi.org/10.1007/s11030-025-11136-3

Vancouver

Malik HN, Jabeen A, Ashraf S, Farooq S, Iqbal H, Ul-Haq Z. Identification of effective synthetic molecules against viral-induced cytokine release syndrome using in silico and in vitro approaches. Molecular Diversity. 2025. doi:10.1007/s11030-025-11136-3

BibTeX
@article{Malik2025,
  author = {Malik, Hira Noor and Jabeen, Almas and Ashraf, Sajda and Farooq, Saba and Iqbal, Hana'a and Ul-Haq, Zaheer},
  title = {Identification of effective synthetic molecules against viral-induced cytokine release syndrome using in silico and in vitro approaches},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-025-11136-3}
}
Kostenlos starten →